Open AccessA prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma
Author(s) -
Elena Zamagni,
Cristinni,
Francesca Patriarca,
Emanuela Englaro,
Paolo Castellucci,
Onelio Geatti,
Patrizia Tosi,
Paola Tacchetti,
Delia Cangini,
Giulia Perrone,
Michela Ceccolini,
Annamaria Brioli,
Silvia Buttignol,
Renato Fanin,
Eugenio Salizzoni,
Michele Baccarani,
Stefano Fanti,
Michèle Cavo
Publication year - 2007
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.10554
Subject(s) - medicine , pelvis , magnetic resonance imaging , radiology , positron emission tomography , nuclear medicine , radiography
Bone lesions in multiple myeloma (MM) have been traditionally detected by whole body X-ray (WBXR) survey although magnetic resonance imaging (MRI) has become the gold standard for detecting MM involvement of the spine and pelvis. The aim of this study was to compare a new technique, positron emission tomography (PET) with 18F fluorodeoxyglucose (FDG) integrated with computed tomography (18F-FDG PET-CT), with MRI and WBXR for baseline assessment of bone disease in MM.